Stephane Palfi
Affiliations: | CEA, University of Paris, Fontenay-aux-Roses, Île-de-France, France |
Area:
Neurodegenerative diseasesGoogle:
"Stephane Palfi"Mean distance: 18 (cluster 29)
Cross-listing: Neuropathology Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tremblay S, Acker L, Afraz A, et al. (2020) An Open Resource for Non-human Primate Optogenetics. Neuron |
| Senova S, Clair AH, Palfi S, et al. (2019) Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: Towards an Individualized Approach. Frontiers in Psychiatry. 10: 905 |
| Senova S, Mallet L, Gurruchaga JM, et al. (2019) Severe Obsessive-Compulsive Disorder Secondary to Neurodegeneration With Brain Iron Accumulation: Complete Remission After Subthalamic Nuclei Deep Brain Stimulation. Biological Psychiatry |
| Badin RA, Binley K, Van Camp N, et al. (2019) Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis. Molecular Therapy. Methods & Clinical Development. 14: 206-216 |
| Palfi S, Gurru J, Le H, et al. (2018) Long-term follow up of a phase 1/2 study of ProSavin, a lentiviral vector gene therapy for Parkinson's disease. Human Gene Therapy. Clinical Development |
| Senova S, Poupon C, Dauguet J, et al. (2018) Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Scientific Reports. 8: 3362 |
| Stewart HJ, Ralph GS, Fong-Wong L, et al. (2016) Optimising transgene configuration and protein fusions to maximise dopamine production for the gene therapy of Parkinson's Disease. Human Gene Therapy. Clinical Development |
| Soulas T, Storme M, Martínez-Martín P, et al. (2016) Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation study. Revue Neurologique. 172: 281-8 |
| Senova S, Hosomi K, Gurruchaga JM, et al. (2016) Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies. Journal of Neurosurgery. 1-9 |
| Palfi S, Gurruchaga JM, Ralph SG, et al. (2016) 367. A Dopamine Gene Therapy for Advanced PD: 4 Years Phase I/II Clinical Update Molecular Therapy. 24: S147 |